Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report

doi:10.12998/wjcc.v10.i29.10794

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3568)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

127

WORD

HTML

1537

Figures (1-2)

451

Tables (1-3)

298

Sum=2455

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

278

Download

835

Sum=1113

Oct 16, 2022 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 16, 2022; 10(29): 10794-10802
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10794

Full Size Figure Download Figure

Figure 2 Abdominal computed tomography. The number of lymph nodes in the abdominal cavity, retroperitoneum, and bilateral inguinal areas increased. The orange arrow shows the enlarged lymph nodes in the abdominal cavity.

Citation: Liu XR, Tian M. Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report. World J Clin Cases 2022; 10(29): 10794-10802
URL: https://www.wjgnet.com/2307-8960/full/v10/i29/10794.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i29.10794